New legislation will be required for FDA to continue collecting biosimilar user fees in future fiscal years. Information related to FDA’s preparation for the third reauthorization of BsUFA will be hosted here on this page as it becomes available.
Similar Posts
Raw Bistro Pet Fare Voluntarily Recalls Frozen Beef Entrée Because of Possible Salmonella Health Risk
October 9, 2025 – Raw Bistro Pet Fare, Cannon Falls, MN is voluntarily recalling two product sizes of its frozen beef dog food because they may be contaminated with Salmonella.Eco Lips, Inc. – 631629 – 08/22/2024
CGMP/Finished Pharmaceuticals/AdulteratedAnesthetic Vaporizer Recall: Draeger Removes Vapor 2000 and Vapor 3000 Vaporizers
Draeger is removing certain Vapor 2000 and Vapor 3000 Vaporizers due to impurities found within a component.Responding to FDA Form 483 Observations at the Conclusion of a Drug CGMP Inspection
Responding to FDA Form 483 Observations at the Conclusion of a Drug CGMP InspectionMedication Health Fraud for Specific Diseases and Conditions
FDA has identified condition-specific medication health fraud scams that can pose significant risks to consumers.FDA Rare Disease Innovation Hub
FDA created the Rare Disease Innovation Hub (the Hub) to serve as a point of collaboration and connectivity between CBER and CDER with the goal of ultimately improving outcomes for patients.